Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
about
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsKIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on MastocytosisChronic mast cell leukemia: a novel leukemia-variant with distinct morphological and clinical featuresMutation D816V alters the internal structure and dynamics of c-KIT receptor cytoplasmic region: implications for dimerization and activation mechanismsTarget interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthMast cell activation syndromes: definition and classification.Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalCellular expression profile for interstitial cells of cajal in bladder - a cell often misidentified as myocyte or myofibroblast.Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT.Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposalSystemic mastocytosis presenting with gastrointestinal, bone and skin involvementMastocytosis: a mutated KIT receptor induced myeloproliferative disorderIdentification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.Systemic mastocytosis presenting as acute appendicitis: a case report and review of the literature.Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816VDiffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature.Histamine: an undercover agent in multiple rare diseases?Diagnosis, progression patterns and prognostication in mastocytosis.European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives.Pathology of the liver sinusoids.Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.Risk factors and management of severe life-threatening anaphylaxis in patients with clonal mast cell disordersCurrent treatment options in patients with mastocytosis: status in 2015 and future perspectives.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts.Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemia.Serotonin and its 5-HT1 receptor in human mastocytosis.Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.Guidelines and diagnostic algorithm for patients with suspected systemic mastocytosis: a proposal of the Austrian competence network (AUCNM)Case Report: Unusual Manifestation of KIT Negative Systemic Mastocytosis.Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.Mastocytosis in children and adults: clinical disease heterogeneityA new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family.Midostaurin: a magic bullet that blocks mast cell expansion and activation.Allogeneic NK cells eradicate myeloblasts but not neoplastic mast cells in systemic mastocytosis associated with acute myeloid leukemia.The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
P2860
Q26778929-F93FB2A6-1920-4DBB-B033-1D3E5D5A5AA3Q26830207-E8FDE745-1930-4629-A10F-6516567654C6Q27026581-995D1276-9797-47F8-A018-977F272BB68AQ28478611-C3F112B5-8CFD-4F04-B697-B8B06EF80798Q28828739-C0CBC976-E026-402A-ABC3-0A6D0FD3C78EQ34035582-AA8C6C66-9018-4E64-9722-9537720F49C2Q34137971-609C264D-7836-4331-A285-16364B6E0088Q34473700-8D645AA0-C769-4C34-94D1-181DDED0FFEEQ34552564-630345E9-5812-403C-A14E-04B32BAAC4D5Q35153623-98E9BBE2-7B04-45F0-9F71-E502E40E1C1DQ35574171-3D0ED4A0-340F-44F6-84B2-FB3FB595EA53Q35929253-8E65CC14-B0CD-48C2-9DAD-8CE3DFFC748BQ36210845-3C6BC3D4-5ECB-4C7B-9CF6-17D176FE8A44Q36406996-5CB492AF-EFF7-415D-B06F-3A04E791D029Q36797114-A5242BEF-8C84-40F0-9256-BF8116FFB09AQ36977300-200D0698-66E2-4B27-B203-30DF0BE9216DQ37144902-F588F9EE-1B75-42C9-9D58-2F5F70426833Q37957219-E5EC549B-3A5C-4640-8A31-E4552A585F36Q37995651-022B37F5-C81E-4561-AE76-A70420D95F78Q38025156-66BE13AC-69D1-4DFF-8FE2-31AC4E60163EQ38062360-1567E53B-F547-4316-8519-AAD78D5FD6E0Q38176084-0BCEF847-2572-4D0A-9622-4BA97DF8CCE9Q38193659-CE90E84F-DEFB-4BE5-B839-2BB93F24831FQ38202204-F3312215-8F60-4382-8827-B4B0A28EAE5CQ38370943-9C8FCFF3-B62C-4DFA-BA74-04D7D64F35C0Q38582624-686766B5-48FA-49BA-9896-4D13B8E19390Q38736625-1E12C98F-716B-4D4B-9608-5315C1C5A66DQ38739710-82963297-7709-43CC-B29E-C2BCCAACA47AQ38777126-91B9EFEF-0C81-419F-BF92-0304BEDFEE10Q38866094-F296827C-F8F5-40C4-BC7B-585E6CC92F6DQ39407815-DFA043E1-D68E-4A10-9B16-60527E149B7CQ39779573-F5CB6EE2-8279-403B-8CF2-B44AFF376278Q40582535-34A3252C-FC8E-4F3F-817E-87B9CF03D01FQ41533457-61C206A9-A5DD-4405-A47C-1EA1CD432B37Q42081445-4CBD8EA6-8115-42FB-9524-91D872180131Q42243338-0418BDB0-C29E-42EF-859D-B1BEF855BEB0Q44060521-55687665-9DB8-4AB8-AD1D-E72F8C512ED0Q47930594-45F7EDA6-A39A-44CD-A5A0-BA16900C003CQ48251471-CD0E6AC4-96B6-49A2-9A11-D97A44648D47Q50035104-44825620-BA9A-4CE0-BEBB-AF2C4876DF0B
P2860
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis, classification a ...... 2010 and future perspectives.
@en
Pathogenesis, classification a ...... 2010 and future perspectives.
@nl
type
label
Pathogenesis, classification a ...... 2010 and future perspectives.
@en
Pathogenesis, classification a ...... 2010 and future perspectives.
@nl
prefLabel
Pathogenesis, classification a ...... 2010 and future perspectives.
@en
Pathogenesis, classification a ...... 2010 and future perspectives.
@nl
P2860
P356
P1476
Pathogenesis, classification a ...... n 2010 and future perspectives
@en
P2093
Michel Arock
P2860
P304
P356
10.1586/EHM.10.42
P50
P577
2010-08-01T00:00:00Z